Ebru Yılmaz Keskin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ebru Yılmaz Keskin has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Ali Fettah
Ankara Etlik City hospital
2 shared publications Ana Catarina Oliveira
Centro Hospitalar e Universitário de Coimbra, Clinic of Hematology, Coimbra, Portugal
2 shared publicationsBanu Gülcan Öksüz
2 shared publications- Celeste Bento
Haematology Department, Centro Hospitalar e Universitario de Coimbra, Portugal
2 shared publications Mahir İğde
2 shared publicationsMahmut Keskin
Pediatrics
2 shared publications
Latest Publications
- Open Access
- 29 May 2025
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 50 (5) , 668-675
Eosin-5′-maleimide (EMA)-binding assay as a diagnostic method of hereditary spherocytosis
Objectives: Erythrocyte membrane disorders are caused by a deficiency of structural proteins in the erythrocyte membrane. Accurate differential diagnosis within this group of disorders (is essential for appropriate management. The eosin-5′-maleimide (EMA) binding assay is a novel test that is used for the differential diagnosis of erythrocyte membrane disorders. In this study, we have examined and reported blood counts, reticulocyte indices, and the EMA binding assay results with clinical findings of cases admitted to our laboratory for suspected red blood cell (RBC) membrane disorder. Methods: We performed the EMA binding assay on the blood samples of 103 patients who were screened for hereditary erythrocyte membrane disorders at the Flow Cytometry Laboratory of Ankara Numune Training and Research Hospital. The total cohort was grouped as patients with hereditary spherocytosis (HS) (n=36) and control group (patients without erythrocyte membrane disorders (n=60), and non-HS patients with a preliminary diagnosis of hemolytic anemia (n=7). The control group included during data collection, the results of the EMA binding assay were recorded along with demographic features, clinical information, morphologic features, blood count parameters, RBC and reticulocyte indices, and a conventional osmotic fragility (OF) test. Receiver Operating Characteristics (ROC) analyses were performed to evaluate the diagnostic accuracy of the EMA binding assay and reticulocyte parameters. Results: Both EMA testing and flow cytometric (FC) OF test were significantly lower in overall (n=36), ≤10-year-old (n=12), and >10-year-old (n=24) patients with HS than in healthy controls (p<0.001). The EMA binding assay had 100 % sensitivity and specificity in screening HS. Conclusions: Combined with conventional blood tests, clinical findings, and medical history, the EMA binding assay is a reliable and convenient tool for screening for HS and differentiating hereditary erythrocyte membrane disorders.
- 29 May 2025
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 50 (5) , 668-675
Open AccessEosin-5′-maleimide (EMA)-binding assay as a diagnostic method of hereditary spherocytosis
Objectives: Erythrocyte membrane disorders are caused by a deficiency of structural proteins in the erythrocyte membrane. Accurate differential diagnosis within this group of disorders (is essential for appropriate management. The eosin-5′-maleimide (EMA) binding assay is a novel test that is used for the differential diagnosis of erythrocyte membrane disorders. In this study, we have examined and reported blood counts, reticulocyte indices, and the EMA binding assay results with clinical findings of cases admitted to our laboratory for suspected red blood cell (RBC) membrane disorder. Methods: We performed the EMA binding assay on the blood samples of 103 patients who were screened for hereditary erythrocyte membrane disorders at the Flow Cytometry Laboratory of Ankara Numune Training and Research Hospital. The total cohort was grouped as patients with hereditary spherocytosis (HS) (n=36) and control group (patients without erythrocyte membrane disorders (n=60), and non-HS patients with a preliminary diagnosis of hemolytic anemia (n=7). The control group included during data collection, the results of the EMA binding assay were recorded along with demographic features, clinical information, morphologic features, blood count parameters, RBC and reticulocyte indices, and a conventional osmotic fragility (OF) test. Receiver Operating Characteristics (ROC) analyses were performed to evaluate the diagnostic accuracy of the EMA binding assay and reticulocyte parameters. Results: Both EMA testing and flow cytometric (FC) OF test were significantly lower in overall (n=36), ≤10-year-old (n=12), and >10-year-old (n=24) patients with HS than in healthy controls (p<0.001). The EMA binding assay had 100 % sensitivity and specificity in screening HS. Conclusions: Combined with conventional blood tests, clinical findings, and medical history, the EMA binding assay is a reliable and convenient tool for screening for HS and differentiating hereditary erythrocyte membrane disorders.
- Open Access
- 1 July 2024
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 59 (4) , 419-421
Life-Threatening Recurrence of Paroxysmal Cold Hemoglobinuria in a Child During Influenza A Infection
Cite this article as: Maslak İC, Selver MB, Kaşkaya Ö, et al. Life-threatening recurrence of paroxysmal cold hemoglobinuria in a child during influenza A infection. Turk Arch Pediatr. 2024;59(4):419-421.
- 1 July 2024
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 59 (4) , 419-421
Open AccessLife-Threatening Recurrence of Paroxysmal Cold Hemoglobinuria in a Child During Influenza A Infection
Cite this article as: Maslak İC, Selver MB, Kaşkaya Ö, et al. Life-threatening recurrence of paroxysmal cold hemoglobinuria in a child during influenza A infection. Turk Arch Pediatr. 2024;59(4):419-421.
- Open Access
- 13 February 2024
- Published by Galenos Yayinevi in The Journal of Pediatric Academy
Validity of Erythrocyte Indices in Differentiation between Iron Deficiency Anemia and β-Thalassemia Trait in Children
Iron deficiency anemia (IDA) and β-thalassemia trait (BTT) are the most common causes of hypochromic microcytic anemia (HMA). Various erythrocyte indices that may help in the initial discrimination between IDA and BTT have been reported, but data evaluating their reliability in children are scarce. We aimed to evaluate the validity of 12 erythrocyte indices in the differentiation between IDA and BTT in children. These indices were red blood cell (RBC) count, Mentzer Index, England and Fraser Index, Srivastava Index, Shine and Lal Index, RBC distribution width (RDW), Ricerca Index, Green and King Index, RDW Index, Sirdah Index, Ehsani Index, and Serdar Index. Among 1,444 children with HMA, 136 (9.4%) were stratified into the IDA group and 137 (9.5%) into the BTT group. Of the 12 indices, the Green and King Index showed the highest reliability, as it had the highest Youden’s index (75.1%). Its sensitivity, specificity, positive predictive value, negative predictive value and correct diagnosis rate were 92.7%, 82.4%, 84.1%, 91.8% and 87.5%, respectively. The second most reliable index was the RDW Index, having a Youden’s index, sensitivity, specificity, positive predictive value, negative predictive value and correct diagnosis rate of 64.0%, 94.2%, 69.9%, 75.9%, 92.2% and 82.0%, respectively. Receiver operating characteristic analysis showed that the revised cut-off values for the Green and King Index and RDW Index had higher sensitivity and specificity levels than the cut-off values commonly used in the literature. The findings of this study suggest the superiority of the Green and King Index and the RDW Index as screening tools in the initial differentiation between IDA and BTT among children with HMA.
- 13 February 2024
- Published by Galenos Yayinevi in The Journal of Pediatric Academy
Open AccessValidity of Erythrocyte Indices in Differentiation between Iron Deficiency Anemia and β-Thalassemia Trait in Children
Iron deficiency anemia (IDA) and β-thalassemia trait (BTT) are the most common causes of hypochromic microcytic anemia (HMA). Various erythrocyte indices that may help in the initial discrimination between IDA and BTT have been reported, but data evaluating their reliability in children are scarce. We aimed to evaluate the validity of 12 erythrocyte indices in the differentiation between IDA and BTT in children. These indices were red blood cell (RBC) count, Mentzer Index, England and Fraser Index, Srivastava Index, Shine and Lal Index, RBC distribution width (RDW), Ricerca Index, Green and King Index, RDW Index, Sirdah Index, Ehsani Index, and Serdar Index. Among 1,444 children with HMA, 136 (9.4%) were stratified into the IDA group and 137 (9.5%) into the BTT group. Of the 12 indices, the Green and King Index showed the highest reliability, as it had the highest Youden’s index (75.1%). Its sensitivity, specificity, positive predictive value, negative predictive value and correct diagnosis rate were 92.7%, 82.4%, 84.1%, 91.8% and 87.5%, respectively. The second most reliable index was the RDW Index, having a Youden’s index, sensitivity, specificity, positive predictive value, negative predictive value and correct diagnosis rate of 64.0%, 94.2%, 69.9%, 75.9%, 92.2% and 82.0%, respectively. Receiver operating characteristic analysis showed that the revised cut-off values for the Green and King Index and RDW Index had higher sensitivity and specificity levels than the cut-off values commonly used in the literature. The findings of this study suggest the superiority of the Green and King Index and the RDW Index as screening tools in the initial differentiation between IDA and BTT among children with HMA.
- Open Access
- 1 May 2021
- Published by Medical Journal of Suleyman Demirel University in SDÜ Tıp Fakültesi Dergisi
- Vol. 28 (COVİD-19 Ö) , 61-66
ÇOCUKLUK ÇAĞI COVID-19 HASTALIĞINDA HEMATOLOJİK BULGULAR VE ANTİKOAGÜLAN KULLANIMI
Ağır akut respiratuvar sendrom koronavirüs-2 (SARS-CoV-2) ajanının yol açtığı Koronavirüs-2019 hastalığı (COVID-2019), bir solunum yolu hastalığı olarak düşünülmekle birlikte, birçok sistemde etkilenmeye yol açabilir. Bu olgularda hematolojik komplikasyonlar izlenebilir. Erişkin COVID-19 hastalarında lenfopeni ve hiperkoagülabilite bildirilmiştir ve bunların varlığı kötü prognoz ile ilişkilendirilmiştir. Pediatrik COVID-19 olgularında izlenen hematolojik bulguların erişkinlerden farklı özellikler gösterebildiği kaydedilmiştir. Gözlemsel çalışmalar, COVID-19 ilişkili hastalık nedeniyle hastaneye yatırılan çocuklarda, erişkinlerdeki gibi, venöz tromboembolizm riskinin arttığına işaret etmektedir. Ancak, etkilenen olgularda antikoagülan tromboprofilaksi önerilerini içeren rehberler ağırlıklı olarak erişkin hastalar için oluşturulmuştur. Bu derlemede SARS-CoV-2 enfeksiyonu olan çocukların hematolojik bulgularının gözden geçirilmesi ve etkilenen çocuklarda kanıta dayalı antikoagülan tromboprofilaksi önerilerinin sunulması amaçlanmıştır.
- 1 May 2021
- Published by Medical Journal of Suleyman Demirel University in SDÜ Tıp Fakültesi Dergisi
- Vol. 28 (COVİD-19 Ö) , 61-66
Open AccessÇOCUKLUK ÇAĞI COVID-19 HASTALIĞINDA HEMATOLOJİK BULGULAR VE ANTİKOAGÜLAN KULLANIMI
Ağır akut respiratuvar sendrom koronavirüs-2 (SARS-CoV-2) ajanının yol açtığı Koronavirüs-2019 hastalığı (COVID-2019), bir solunum yolu hastalığı olarak düşünülmekle birlikte, birçok sistemde etkilenmeye yol açabilir. Bu olgularda hematolojik komplikasyonlar izlenebilir. Erişkin COVID-19 hastalarında lenfopeni ve hiperkoagülabilite bildirilmiştir ve bunların varlığı kötü prognoz ile ilişkilendirilmiştir. Pediatrik COVID-19 olgularında izlenen hematolojik bulguların erişkinlerden farklı özellikler gösterebildiği kaydedilmiştir. Gözlemsel çalışmalar, COVID-19 ilişkili hastalık nedeniyle hastaneye yatırılan çocuklarda, erişkinlerdeki gibi, venöz tromboembolizm riskinin arttığına işaret etmektedir. Ancak, etkilenen olgularda antikoagülan tromboprofilaksi önerilerini içeren rehberler ağırlıklı olarak erişkin hastalar için oluşturulmuştur. Bu derlemede SARS-CoV-2 enfeksiyonu olan çocukların hematolojik bulgularının gözden geçirilmesi ve etkilenen çocuklarda kanıta dayalı antikoagülan tromboprofilaksi önerilerinin sunulması amaçlanmıştır.
- 3 March 2021
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 44 (1) , e91-e95
Association of Maternal Vitamin B12 Status With Infant Findings and Neurodevelopment in Vitamin B12-Deficient Breast-fed Babies
Few studies have examined the association between maternal vitamin B12 status and their breast-fed infants’ findings. The objective of this study was to analyze the association of maternal B12 status with infant findings including neurodevelopmental outcome in breast-fed babies with B12 deficiency. Correlation analyses between the laboratory findings of infants with B12 deficiency (n=120) and their mothers were performed and the association of maternal B12 status with infant findings including the Denver-II developmental screening test (DDST II) results was examined. There was a significant correlation between infant and maternal B12 levels (r=0.222; P=0.030), and between infant and maternal homocysteine (Hcy) levels (r=0.390; Pr=0.404; P=0.001) and infant mean corpuscular volume (r=0.461; P12 (196.9±41.2 vs. 247.0±77.0 pg/mL; P=0.018) and higher Hcy levels (17.3±5.0 vs. 10.7±3.1 µmol/L; P12 status may be related to impaired neurodevelopment in breast-fed infants with vitamin B12 deficiency. Pregnant and lactating women should be offered easy access to healthy nutrition and vitamin B12 supplements.
- 3 March 2021
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 44 (1) , e91-e95
Association of Maternal Vitamin B12 Status With Infant Findings and Neurodevelopment in Vitamin B12-Deficient Breast-fed Babies
Few studies have examined the association between maternal vitamin B12 status and their breast-fed infants’ findings. The objective of this study was to analyze the association of maternal B12 status with infant findings including neurodevelopmental outcome in breast-fed babies with B12 deficiency. Correlation analyses between the laboratory findings of infants with B12 deficiency (n=120) and their mothers were performed and the association of maternal B12 status with infant findings including the Denver-II developmental screening test (DDST II) results was examined. There was a significant correlation between infant and maternal B12 levels (r=0.222; P=0.030), and between infant and maternal homocysteine (Hcy) levels (r=0.390; Pr=0.404; P=0.001) and infant mean corpuscular volume (r=0.461; P12 (196.9±41.2 vs. 247.0±77.0 pg/mL; P=0.018) and higher Hcy levels (17.3±5.0 vs. 10.7±3.1 µmol/L; P12 status may be related to impaired neurodevelopment in breast-fed infants with vitamin B12 deficiency. Pregnant and lactating women should be offered easy access to healthy nutrition and vitamin B12 supplements.
- 31 December 2019
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 9 (4) , 359-364
Retrospective Evaluation Of Children After Stem Cell Transplantation: Single Center Experience
Aim: Analysis of the data of children following stem cell transplantation.Materials and Methods: A total of 44 children who received stem cell transplant between February 2009 and May 2011 were evaluated retrospectively. Results: Among the patients with a mean age of 9.6 ± 4.63 years, 20 (45.5%) were male, whereas 24 (54.5%) were female. The initial diagnosis of the patients with decreasing order of frequency was as follows: thalassemia major (n=15), acute leukemia (n=9), Fanconi aplastic anemia (n=6), aplastic anemia (n=5) and other disorders (n=9). Disease-free survival in two years was observed in 27 (61.3%) of patients. Relapse occurred in 8 (18.1%) patients, whereas 9 (20.4%) patients died. The mortality was transplant-related in two cases, whereas it was due to progression of the underlying disease in 7 (15.9%) patients. Conclusion: As the stem cell transplantation has become widespread in Türkiye recently, its data are valuable. We found high incidence of mucositis and infection due to myeloablative regimens. The limitation of our study is the small number of patients included. Though, results obtained here are similar to those of national and international studies.
- 31 December 2019
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 9 (4) , 359-364
Retrospective Evaluation Of Children After Stem Cell Transplantation: Single Center Experience
Aim: Analysis of the data of children following stem cell transplantation.Materials and Methods: A total of 44 children who received stem cell transplant between February 2009 and May 2011 were evaluated retrospectively. Results: Among the patients with a mean age of 9.6 ± 4.63 years, 20 (45.5%) were male, whereas 24 (54.5%) were female. The initial diagnosis of the patients with decreasing order of frequency was as follows: thalassemia major (n=15), acute leukemia (n=9), Fanconi aplastic anemia (n=6), aplastic anemia (n=5) and other disorders (n=9). Disease-free survival in two years was observed in 27 (61.3%) of patients. Relapse occurred in 8 (18.1%) patients, whereas 9 (20.4%) patients died. The mortality was transplant-related in two cases, whereas it was due to progression of the underlying disease in 7 (15.9%) patients. Conclusion: As the stem cell transplantation has become widespread in Türkiye recently, its data are valuable. We found high incidence of mucositis and infection due to myeloablative regimens. The limitation of our study is the small number of patients included. Though, results obtained here are similar to those of national and international studies.
- Open Access
- 19 July 2019
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 36 (4) , 299-301
A rare cause of cyanosis since birth: Hb M-Iwate
- 19 July 2019
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 36 (4) , 299-301
Open AccessA rare cause of cyanosis since birth: Hb M-Iwate
- Open Access
- 26 January 2018
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 35 (3) , 200-202
First report of an SH2D1A mutation associated with X-linked lymphoproliferative disease in Turkey
- 26 January 2018
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 35 (3) , 200-202
Open AccessFirst report of an SH2D1A mutation associated with X-linked lymphoproliferative disease in Turkey
- 6 January 2018
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 85 (7) , 517-522
Association between Maternal and Infantile Markers of Cobalamin Status During the First Month Post-Delivery
Objective Exclusively breast-fed infants born to vitamin B12 (cobalamin, cbl)-deficient mothers can develop symptoms within a few months following delivery. The authors aimed to assess the relationship between maternal and infantile markers of cbl status. Methods In 240 full-term infants (age, 2–30 d) admitted to Samsun Maternity and Child Health Hospital and their mothers, complete blood count testing and serum cbl, folate and plasma total homocysteine (tHcy) measurements were performed. In the mothers, serum ferritin and holotranscobalamin (holoTC) levels were measured additionally. Results Among the infants, 146 (60.8%) had cbl deficiency (serum cbl 10 μmol/L), in 35 (23.8%) of these 147 infants tHcy level being markedly elevated (>20 μmol/L). None of the infants had folate deficiency. In the correlational analysis between maternal and infantile markers associated with cbl status, the strongest correlation was observed between maternal holoTC and infantile tHcy (r = −0.49, p < 0.001), followed by the correlation between maternal tHcy and infantile tHcy (r = 0.47, p < 0.001). The weakest correlations were found between maternal cbl and infantile cbl (r = 0.28, p < 0.001), and between maternal cbl and infantile tHcy (r = −0.25, p < 0.001). Conclusions Maternal cbl status is an important determinant of infantile cbl status. Both maternal holoTC and tHcy may assist in predicting infantile cbl status. The finding of high prevalence of maternal and infantile cbl deficiency in this study points towards the need for effective strategies to prevent cbl deficiency in women prior to getting pregnant.
- 6 January 2018
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 85 (7) , 517-522
Association between Maternal and Infantile Markers of Cobalamin Status During the First Month Post-Delivery
Objective Exclusively breast-fed infants born to vitamin B12 (cobalamin, cbl)-deficient mothers can develop symptoms within a few months following delivery. The authors aimed to assess the relationship between maternal and infantile markers of cbl status. Methods In 240 full-term infants (age, 2–30 d) admitted to Samsun Maternity and Child Health Hospital and their mothers, complete blood count testing and serum cbl, folate and plasma total homocysteine (tHcy) measurements were performed. In the mothers, serum ferritin and holotranscobalamin (holoTC) levels were measured additionally. Results Among the infants, 146 (60.8%) had cbl deficiency (serum cbl 10 μmol/L), in 35 (23.8%) of these 147 infants tHcy level being markedly elevated (>20 μmol/L). None of the infants had folate deficiency. In the correlational analysis between maternal and infantile markers associated with cbl status, the strongest correlation was observed between maternal holoTC and infantile tHcy (r = −0.49, p < 0.001), followed by the correlation between maternal tHcy and infantile tHcy (r = 0.47, p < 0.001). The weakest correlations were found between maternal cbl and infantile cbl (r = 0.28, p < 0.001), and between maternal cbl and infantile tHcy (r = −0.25, p < 0.001). Conclusions Maternal cbl status is an important determinant of infantile cbl status. Both maternal holoTC and tHcy may assist in predicting infantile cbl status. The finding of high prevalence of maternal and infantile cbl deficiency in this study points towards the need for effective strategies to prevent cbl deficiency in women prior to getting pregnant.
- Open Access
- 23 August 2017
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 34 (4) , 372-373
First Observation of Hemoglobin San Diego, a High Oxygen Affinity Hemoglobin Variant, in Turkey
- 23 August 2017
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 34 (4) , 372-373
Open AccessFirst Observation of Hemoglobin San Diego, a High Oxygen Affinity Hemoglobin Variant, in Turkey